EPISODE · May 31, 2024 · 23 MIN
Biologics in COPD: Why, when, and who
from The APAPP Podcast · host Association of Pulmonary Advanced Practice Providers
Dr. Jamie Rutland discusses the role of biologic therapy in COPD. He explains that type 2 inflammation, characterized by the presence of eosinophils, is a key factor in COPD. He also discusses the use of biologics to target this inflammation and reduce exacerbations in COPD patients. Claim your 0.5 CME credits here: https://forms.gle/42yHmF8UpemVhdDJA
What this episode covers
Dr. Jamie Rutland discusses the role of biologic therapy in COPD. He explains that type 2 inflammation, characterized by the presence of eosinophils, is a key factor in COPD. He also discusses the use of biologics to target this inflammation and reduce exacerbations in COPD patients. Claim your 0.5 CME credits here: https://forms.gle/42yHmF8UpemVhdDJA
NOW PLAYING
Biologics in COPD: Why, when, and who
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m